Ursprung des Netzwerks ersten Grades von Shawn Benoit
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shawn Benoit
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| ESSEC Business School | College/University | Undergraduate Degree Undergraduate Degree | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
| Creabilis SA | Director/Board Member | ||
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
STJ Advisors LLP
 STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John. | Investment Managers | Corporate Officer/Principal | |
Pennie & Edmonds LLP
 Pennie & Edmonds LLP Miscellaneous Commercial ServicesCommercial Services Pennie & Edmonds LLP provides legal services. The company was founded on January 27, 1997 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OCUPHIRE PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Serono France SA | Chairman | ||
Gide Loyrette Nouel
 Gide Loyrette Nouel Miscellaneous Commercial ServicesCommercial Services Gide Loyrette Nouel is an international law firm founded in 1920. The private company is based in Paris, FR, and has subsidiaries in France and United Kingdom. The firm has a leading position in all areas of business law, including insurance, banking and finance, competition and international trade, and tax. Gide brings together 550 lawyers, including around a hundred partners, and operates in many countries with 11 offices. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Director/Board Member | |
| STALLERGENES | Pharmaceuticals: Major | Chief Executive Officer | |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Founder | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Chief Executive Officer | |
Greer Laboratories, Inc.
 Greer Laboratories, Inc. Medical/Nursing ServicesHealth Services Greer Laboratories, Inc. develops and provides allergy immunotherapy products and services for treating humans and animals. The company was founded in 1904 and is headquartered in Lenoir, NC. | Medical/Nursing Services | Director/Board Member | |
| Université Paris II Panthéon Assas | College/University | Undergraduate Degree | |
| Yale University | College/University | Graduate Degree | |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | ||
Partech Partners SAS
 Partech Partners SAS Investment ManagersFinance Partech Partners SAS (Partech Partners) is a venture capital firm founded in 1982. The firm is headquartered in France. | Investment Managers | Private Equity Investor | |
| University of Mumbai | College/University | Doctorate Degree | |
| Gujarat University | College/University | Undergraduate Degree | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 14 |
| Frankreich | 13 |
| Schweiz | 9 |
| Vereinigtes Königreich | 8 |
| Belgien | 3 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 6 |
| Process Industries | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 126 |
| Corporate Officer/Principal | 38 |
| Independent Dir/Board Member | 32 |
| Chairman | 20 |
| Chief Executive Officer | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Johan Rutger Christenson | 35 |
| Catherine Moukheibir | 29 |
| Jean-Pierre Garnier | 28 |
| Michael Davidson | 27 |
| Denis Lucquin | 26 |
| Marc Rivière | 18 |
| Christian Chavy | 18 |
| Barbara Yanni | 13 |
| Narendra D. Lalwani | 8 |
| Daniela Oniciu | 8 |
| Laura Coruzzi | 7 |
| Karen Noël | 6 |
| William F. Brinkerhoff | 5 |
| Cyrille Tupin | 5 |
| Renee Benghozi | 3 |
- Börse
- Insiders
- Shawn Benoit
- Unternehmensverbindungen
